Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;34(1):e4710.
doi: 10.1002/bmc.4710. Epub 2019 Nov 19.

Protein precipitation method for determination of clobazam and N-desmethylclobazam in human plasma by LC-MS/MS

Affiliations

Protein precipitation method for determination of clobazam and N-desmethylclobazam in human plasma by LC-MS/MS

Astghik Mikayelyan et al. Biomed Chromatogr. 2020 Jan.

Abstract

A protein precipitation method for the determination of clobazam (CLB) and its major active metabolite N-desmethylclobazam (N-CLB) in human plasma by liquid chromatography tandem mass spectrometry (LC-MS/MS) was established. CLB and N-CLB were extracted from human plasma samples by protein precipitation with methanol. Analyte separation was done using a Phenomenex Kinetex™ Biphenyl (50 × 2.1 mm, 1.7 μm) column using isocratic elution with a mobile phase of 5 mm ammonium formate with 0.01% ammonium hydroxide (40%) and methanol (60%) at a flow rate of 0.4 mL/min and an injection volume of 10 μL. The detection was performed on a triple quadrupole mass spectrometer in multiple reaction monitoring mode to monitor the precursor-to-product ion transitions of m/z 301.1 → 259.0, 306.0 → 263.9 for CLB and CLB-D5 and 287.0 → 245.0, 292.0 → 250.0 for N-CLB and N-CLB-D5 in positive electrospray ionization mode, respectively. The method was validated over a concentration range of 2.0-750 ng/mL for CLB and 0.7-200 ng/mL for N-CLB on SCIEX Triple Quad 4500 MS System. Total run time was 5 min. This method has been designed for bioequivalence study for formulations containing 20 mg of CLB.

Keywords: LC-MS/MS; N-desmethylclobazam; PPT; clobazam; plasma.

PubMed Disclaimer

References

REFERENCES

    1. Akerman, K. K. (1996). Analysis of clobazam and its active metabolite norclobazam in plasma and serum using HPLC/DAD. Scandinavian Journal of Clinical and Laboratory Investigation, 56(7), 609-614.
    1. Besson, M., Daali, Y., Di Lio, A., Dayer, P., Zeilhofer, H. U., & Desmeules, J. (2013). Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: A pharmacokinetic-pharmacodynamic study. Basic & Clinical Pharmacology & Toxicology, 112(3), 192-197. https://doi.org/10.1111/bcpt.12017
    1. Bolner, A., Tagliaro, F., & Lomeo, A. (2001). Optimised determination of clobazam in human plasma with extraction and high-performance liquid chromatography analysis. Journal of Chromatography. B, Biomedical Sciences and Applications, 750(1), 177-180.
    1. Christian, S., & Shivprakash, R. P. (2018). A rapid and sensitive LC-MS/MS assay for the determination of clobazam in human plasma using electro spray ionization technology. International Journal of Pharmaceutical Sciences and Research, 9(6), 2369-2377.
    1. Déglon, J., Versace, F., Lauer, E., Widmer, C., Mangin, P., Thomas, A., & Staub, C. (2012). Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment. Bioanalysis, 4(11), 1337-1350.

LinkOut - more resources